Patents by Inventor Shoji Hisada

Shoji Hisada has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bicyclic compound and use thereof for inhibiting SUV39H2
    Patent number: 10508109
    Abstract: The present invention directs to a compound represented by formula (I).
    Type: Grant
    Filed: September 12, 2016
    Date of Patent: December 17, 2019
    Assignee: ONCOTHERAPY SCIENCE, INC.
    Inventors: Yo Matsuo, Shoji Hisada, Yusuke Nakamura, Anjan Chakrabarti, Manish Rawat, Sanjay Rai, Arvapalli Venkata Satyanarayana, Zhiyong Duan, Arindam Talukdar, Srinivas Ravula, Helene Decornez
  • BICYCLIC COMPOUND AND USE THEREOF FOR INHIBITING SUV39H2
    Publication number: 20180273529
    Abstract: The present invention directs to a compound represented by formula (I).
    Type: Application
    Filed: September 12, 2016
    Publication date: September 27, 2018
    Inventors: YO MATSUO, Shoji Hisada, Yusuke Nakamura, Anjan Chakrabarti, Manish Rawat, Sanjay Rai, Arvapalli Venkata Satyanarayana, Zhiyong Duan, Arindam Talukdar, Srinivas Ravula, Helene Decornez
  • Tricyclic compounds and PBK inhibitors containing the same
    Patent number: 9453025
    Abstract: Tricyclic compounds are provided. These compounds are PBK inhibitors, and are useful for the treatment of PBK related diseases, including cancer.
    Type: Grant
    Filed: December 9, 2014
    Date of Patent: September 27, 2016
    Assignee: OncoTherapy Science, Inc.
    Inventors: Yusuke Nakamura, Yo Matsuo, Shoji Hisada, Feryan Ahmed, Raymond Huntley, Zohreh Sajjadi-Hashemi, David M. Jenkins, Robert B. Kargbo, Wenge Cui, Polivina Jolicia F. Gauuan, Joel R. Walker, Helene Decornez, Mahender Gurram
  • 1,5-naphthyridine derivatives and MELK inhibitors containing the same
    Patent number: 9345709
    Abstract: The present invention directs a compound represented by formula (I).
    Type: Grant
    Filed: May 21, 2015
    Date of Patent: May 24, 2016
    Assignee: OncoTherapy Science, Inc.
    Inventors: Yo Matsuo, Shoji Hisada, Yusuke Nakamura, Feryan Ahmed, Joel R. Walker, Raymond Huntley
  • 1,5-NAPHTHYRIDINE DERIVATIVES AND MELK INHIBITORS CONTAINING THE SAME
    Publication number: 20150328225
    Abstract: The present invention directs a compound represented by formula (I).
    Type: Application
    Filed: May 21, 2015
    Publication date: November 19, 2015
    Inventors: Yo MATSUO, Shoji HISADA, Yusuke NAKAMURA, Feryan AHMED, Joel R. WALKER, Raymond HUNTLEY
  • Quinoline derivatives and MELK inhibitors containing the same
    Patent number: 9120749
    Abstract: The present invention directs a compound represented by formula (I).
    Type: Grant
    Filed: July 28, 2011
    Date of Patent: September 1, 2015
    Assignee: ONCOTHERAPY SCIENCE, INC.
    Inventors: Yo Matsuo, Shoji Hisada, Yusuke Nakamura, Feryan Ahmed, Raymond Huntley, Joel R. Walker, Helene Decornez
  • Tricyclic Compounds and PBK Inhibitors Containing the Same
    Publication number: 20150183799
    Abstract: Tricyclic compounds are provided. These compounds are PBK inhibitors, and are useful for the treatment of PBK related diseases, including cancer.
    Type: Application
    Filed: December 9, 2014
    Publication date: July 2, 2015
    Inventors: Yusuke NAKAMURA, Matsuo YO, Shoji HISADA, Feryan AHMED, Raymond HUNTLEY, Zohreh SAJJADI-HASHEMI, David M. JENKINS, Robert B. KARGBO, Wenge CUI, Polivina Jolicia F. GAUUAN, Joel R. WALKER, Helene DECORNEZ, Mahender GURRAM
  • 1,5-naphthyridine derivatives and MELK inhibitors containing the same
    Patent number: 9067937
    Abstract: The present invention directs a compound represented by formula (I).
    Type: Grant
    Filed: December 21, 2012
    Date of Patent: June 30, 2015
    Assignee: OncoTherapy Science, Inc.
    Inventors: Yo Matsuo, Shoji Hisada, Yusuke Nakamura, Feryan Ahmed, Joel R. Walker, Raymond Huntley
  • Tricyclic compounds and PBK inhibitors containing the same
    Patent number: 8962648
    Abstract: Tricyclic compounds are provided. These compounds are PBK inhibitors, and are useful for the treatment of PBK related diseases, including cancer.
    Type: Grant
    Filed: March 29, 2011
    Date of Patent: February 24, 2015
    Assignee: OncoTherapy Science, Inc.
    Inventors: Yusuke Nakamura, Yo Matsuo, Shoji Hisada, Feryan Ahmed, Raymond Huntley, Zohreh Sajjadi-Hashemi, David M. Jenkins, Robert B. Kargbo, Wenge Cui, Polivina Jolicia F. Gauuan, Joel R. Walker, Helene Decornez, Mahender Gurram
  • 1,5-NAPHTHYRIDINE DERIVATIVES AND MELK INHIBITORS CONTAINING THE SAME
    Publication number: 20150005302
    Abstract: The present invention directs a compound represented by formula (I).
    Type: Application
    Filed: December 21, 2012
    Publication date: January 1, 2015
    Inventors: Yo Matsuo, Shoji Hisada, Yusuke Nakamura, Feryan Ahmed, Joel R. Walker, Raymond Huntley
  • QUINOLINE DERIVATIVES AND MELK INHIBITORS CONTAINING THE SAME
    Publication number: 20130217671
    Abstract: The present invention directs a compound represented by formula (I).
    Type: Application
    Filed: July 28, 2011
    Publication date: August 22, 2013
    Inventors: Yo Matsuo, Shoji Hisada, Yusuke Nakamura, Feryan Ahmed, Raymond Huntley, Joel R. Walker, Helene Decomez
  • TRICYCLIC COMPOUNDS AND PBK INHIBITORS CONTAINING THE SAME
    Publication number: 20130178459
    Abstract: Tricyclic compounds are provided. These compounds are PBK inhibitors, and are useful for the treatment of PBK related diseases, including cancer.
    Type: Application
    Filed: March 29, 2011
    Publication date: July 11, 2013
    Applicant: Oncotherapy Science, Inc.
    Inventors: Yusuke Nakamura, Yo Matsuo, Shoji Hisada, Feryan Ahmed, Raymond Huntley, Zohreh Sajjadi-Hashemi, David M. Jenkins, Robert B. Kargbo, Wenge Cui, Polivina Jolicia F. Gauuan, Joel R. Walker, Helene Decornez, Mahender Gurram
  • GLYCOGEN SYNTHASE KINASE-3 BETA INHIBITORS CONTAINING 7-HYDROXY-BENZOIMIDAZOLE-4-YL-METHANONE DERIVATIVES
    Publication number: 20110301146
    Abstract: GSK-3beta inhibitors comprising 7-Hydroxy-benzoimidazole-4-yl-methanone Derivatives are provided. For example, the inhibitors have following general formula (I).
    Type: Application
    Filed: September 29, 2009
    Publication date: December 8, 2011
    Applicant: ONCOTHERAPY SCIENCE, INC.
    Inventors: Yo Matsuo, Ryuji Ohsawa, Shoji Hisada
  • 7-Hydroxy-benzoimidazole-4-yl-methanone Derivatives and PBK Inhibitors Containing the Same
    Publication number: 20110263566
    Abstract: 7-Hydroxy-benzoimidazole-4-yl-methanone Derivatives, which are useful for PBK inhibitors, are provided.
    Type: Application
    Filed: July 30, 2009
    Publication date: October 27, 2011
    Inventors: Yo Matsuo, Yingfu Li, Joel Walker, Feryan Ahmed, Ryuji Ohsawa, Shoji Hisada
  • Benzoimidazole Derivatives and Glycogen Synthase Kinase-3 Beta Inhibitors Containing the Same
    Publication number: 20110190351
    Abstract: Benzoimidazole Derivatives are provided. The compounds of the present invention are useful for Glycogen Synthase Kinase-3 Beta Inhibitors.
    Type: Application
    Filed: July 30, 2009
    Publication date: August 4, 2011
    Applicant: Oncotherapy Science, Inc.
    Inventors: Mitsuaki Ohtani, Yo Matsuo, Yingfu Li, Joel R. Walker, David M. Jenkins, Feryan Ahmed, Ryuji Ohsawa, Shoji Hisada